R&D Sponsored Birmingham: The UK’s new epicentre of health innovation Birmingham has a rich history as a manufacturing and innovation powerhouse in the UK
News Novo Nordisk closes on EU okay for haemophilia antibody Novo Nordisk's anti-TFPI antibody concizumab has been backed for approval in the EU as a once-daily drug to prevent bleeding episodes in people with haemophilia.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.